Jean-Yves Blay, MD, PhD is a medical oncologist, General Director of the Centre Leon Bérard (CLB), the Comprehensive Cancer Centre of Lyon France since December 2014. He also serves as the President of the French Federation of Cancer Centers Unicancer, the network of 18 Comprehensive Cancer Centers in France. Professor Jean-Yves Blay will help bolster Tersan Pharmaceuticals Ltd’s clinical expertise in the field of Oncology and expand the company’s academic and pharmaceutical collaborations internationally.

Professor Blay is currently Director of Public Policy of the European Society for Medical Oncology (ESMO), serving on the ESMO Executive Board and ESMO Council. He advises various national and international institutions and research organizations and is an active member of several oncology scientific organizations and societies, such as ESMO, CTOS, ASCO and AACR.

Professor Blay is managing several research cooperative groups and networks. He is the Director of the LYRICAN Innovative program of excellence for cancer research granted by the INCA since 2012.  He is also President of the French Sarcoma Group since 2005, the Network director of NETSARC+ network of sarcoma reference center for the INCA since 2019. He serves as Secretary for the World Sarcoma Network (WSN), a think tank of all worldwide sarcoma research groups, as well as the Network Coordinator of ERN-EURACAN, designated by the EU Commission in 2016 to improve the quality of care for patients with rare cancers in the European Union. Previously, he served as the President of EORTC.